Please assess the completion status of the following clinical trial:

Trial Title: Enhancing Patient Ability to Understand and Utilize Complex Information Concerning Medication Self-management

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 18 years or older~2. Able to speak and read in English~3. Physician confirmed RA define by 1987 American College of Rheumatology criteria~4. Moderate or highly active rheumatoid arthritis (assess by Routine Assessment of Patient Index Data 3 (RAPID3) score \> 2.0) and~5. Physician indicates patient is a candidate for initiation or escalation of Disease-modifying antirheumatic drug (DMARD) therapy~Exclusion Criteria:~1. Hearing or visually impaired

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Other CMI Only (Type: ACTIVE_COMPARATOR): Approximately 75 participants will be assigned to this study group. Participants will ONLY receive medication guides, or other comparable Consumer Medication Information (CMI), for rheumatoid arthritis medications.
- Other CMI & SMART Program (Type: EXPERIMENTAL): Approximately 75 participants will be assigned to this study group. Participants will receive medication guides, or other comparable Consumer Medication Information (CMI), for rheumatoid arthritis medications AND will be enrolled into the Strategic Memory Advanced Reasoning Training (SMART) Program.
- Drug Facts Boxes Only (Type: EXPERIMENTAL): Approximately 75 participants will be assigned to this study group. Participants will ONLY receive Drug Facts Boxes for rheumatoid arthritis medications.
- Drug Facts Boxes & SMART Program (Type: EXPERIMENTAL): Approximately 75 participants will be assigned to this study group. Participants will receive Drug Facts Boxes for rheumatoid arthritis medicationsAND will be enrolled into the Strategic Memory Advanced Reasoning Training (SMART) Program.

Based on this trial design, predict the completion outcome and termination type (if applicable).